cbdMD (YCBD) Change in Acquisitions & Divestments (2020)
cbdMD (YCBD) posted Change in Acquisitions & Divestments of $540000.0 for Q4 2020.
cbdMD (YCBD) Change in Acquisitions & Divestments (2020) Analysis & Trends
cbdMD has reported Change in Acquisitions & Divestments for 1 years, with the latest figure at $540000.0 in Q4 2020.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $540000.0 in Q4 2020, while the trailing twelve-month figure through Sep 2022 was $540000.0 (changed N/A YoY) and the FY2023 annual result came in at $1.0 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments steadied at $540000.0 in Q4 2020 per YCBD's latest filing.
- Over five years, Change in Acquisitions & Divestments peaked at $540000.0 in Q4 2020 and troughed at $540000.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 540,000.00 |
| Dec 31, 2020 | 540,000.00 |